CNS & Neurological Disorders - Drug Targets
Title:Editorial: Combining Forces to Improve Alzheimer’s Disease Drug Discovery: The Symptomatic Battle
Volume: 15 Issue: 7
Author(s): Julie Deguil, Alexandra Auffret, Esther Schenker, Fabienne Aujard, Yves Lamberty, David Bartrès-Faz, Olivier Blin, Joëlle Micallef, Jill C. Richardson and Régis Bordet
Affiliation:
Export Options
About this article
Cite this article as:
Deguil Julie, Auffret Alexandra, Schenker Esther, Aujard Fabienne, Lamberty Yves, Bartrès-Faz David, Blin Olivier, Micallef Joëlle, Richardson C. Jill and Bordet Régis, Editorial: Combining Forces to Improve Alzheimer’s Disease Drug Discovery: The Symptomatic Battle, CNS & Neurological Disorders - Drug Targets 2016; 15 (7) . https://dx.doi.org/10.2174/187152731507160808200737
DOI https://dx.doi.org/10.2174/187152731507160808200737 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nuclear Medicine: Proof of Principle for Targeted Drugs in Diagnosis and Therapy
Current Pharmaceutical Design Association Study of IL-4 -590 C/T and DDX39B -22 G/C Polymorphisms with the Risk of Late-Onset Alzheimer’s Disease in Iranian Population
Current Aging Science Human T-Cell Leukemia Virus Type 1: Transition from Latent Infection to Pathogenic Progression and Implications for Molecular Therapy
Current Cancer Therapy Reviews PPAR-γ and Wnt Regulate the Differentiation of MSCs into Adipocytes and Osteoblasts Respectively
Current Stem Cell Research & Therapy Mitochondrial Therapeutics for Cardioprotection
Current Pharmaceutical Design Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Small Heat Shock Proteins: Recent Advances in Neuropathy
Current Neurovascular Research QSAR Study on a Series of Aryl Carboxylic Acid Amide Derivatives as Potential Inhibitors of Dihydroorotate Dehydrogenase (DHODH)
Medicinal Chemistry Urinary Steroid Measurements in Some Endocrine and Psychiatric Diseases
Current Medicinal Chemistry Non-Steroidal Anti-Inflammatory Drugs as Anti-Amyloidogenic Compounds
Current Pharmaceutical Design Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review
Current Neuropharmacology Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers
Current Pharmaceutical Design Supplements, Diets and Other Complementary and Alternative Interventions in Adolescent Mental Health
Adolescent Psychiatry Prospects for Caspase Inhibitors
Mini-Reviews in Medicinal Chemistry Yoga may Prevent Cytokine Storm in COVID-19
Coronaviruses N-Sulfonic Acids: New, Efficient and Reusable Catalysts for the Acceleration of Organic Reactions
Current Organic Chemistry Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives
Current Pharmaceutical Design Phytocannabinoids and Endocannabinoids
Current Drug Abuse Reviews Injecting Illicit Substances Epidemic and Infective Endocarditis
Infectious Disorders - Drug Targets Proteomic Strategies for the Analysis of Carbonyl Groups on Proteins
Current Protein & Peptide Science